Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
sitagliptin (januvia) (1 trial)
Diabetes, Gestational (Phase 3)
Insulin Resistance (Phase 3)
Trials (1 total)
Trial APIs (1 total)